Pharma
A scarcity of VC dollars is contributing to a lack of vaccines for many infectious diseases, report finds
Biotechs developing vaccines for infectious diseases brought in just 3.4% of total biotech VC funding over the last decade.
Infectious Disease Therapies
In-depth reporting on infectious disease therapies, from market shifts and clinical breakthroughs to the essential updates shaping the sector.
Navigate the healthcare industry
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.
By subscribing, you accept our Terms & Privacy Policy.
